CoChat
Cited by 160

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

2020 international consensus on ANCA testing beyond systemic vasculitis

Open access
Moiseev, Sergey, Cohen Tervaert, Jan Willem, Arimura, Yoshihiro, Bogdanos, Dimitrios P., Csernok, Elena, Damoiseaux, Jan, Ferrante, Marc, Flores-Suárez, Luis Felipe, Fritzler, Marvin J., Invernizzi, Pietro, Jayne, David, Jennette, J. Charles, Little, Mark A., McAdoo, Stephen P., Novikov, Pavel, Pusey, Charles D., Radice, Antonella, Salama, Alan D., Savige, Judith A., Segelmark, Mårten, Shoenfeld, Yehuda, Sinico, Renato A., Sousa, Maria-José, Specks, Ulrich, Terrier, Benjamin, Tzioufas, Athanasios G., Vermeire, Severine, Zhao, Ming-Hui, Bossuyt, Xavier · 2020 · Autoimmunity Reviews

Abstract

This document follows up on a 2017 revised international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic polyangiitis and focuses on the clinical and diagnostic value of ANCA detection in patients with connective tissue diseases, idiopathic interstitial pneumonia, autoimmune liver diseases, inflammatory bowel diseases, anti-glomerular basement membrane (GBM) disease, infections, malignancy, and during drug treatment. Current evidence suggests that in certain settings beyond systemic vasculitis, ANCA may have clinical, pathogenic and/or diagnostic relevance. Antigen-specific ANCA targeting proteinase-3 and myeloperoxidase should be tested by solid phase immunoassays in any patient with clinical features suggesting ANCA-associated vasculitis and in all patients with anti-GBM disease, idiopathic interstitial pneumonia, and infective endocarditis associated with nephritis, whereas in patients with other aforementioned disorders routine ANCA testing is not recommended. Among patients with autoimmune liver diseases or inflammatory bowel diseases, ANCA testing may be justified in patients with suspected autoimmune hepatitis type 1 who do not have conventional autoantibodies or in case of diagnostic uncertainty to discriminate ulcerative colitis from Crohn's disease. In these cases, ANCA should be tested by indirect immunofluorescence as the target antigens are not yet well characterized. Many questions concerning the optimal use of ANCA testing in patients without ANCA-associated vasculitis remain to be answered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.autrev.2020.102618

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 160

Metadata

Authors
Moiseev, S., Cohen Tervaert, J. W., Arimura, Y., Bogdanos, D. P., Csernok, E., Damoiseaux, J., Ferrante, M., Flores-Suárez, L. F., Fritzler, M. J., Invernizzi, P., Jayne, D., Jennette, J. C., Little, M. A., McAdoo, S. P., Novikov, P., Pusey, C. D., Radice, A., Salama, A. D., Savige, J. A., Segelmark, M., Shoenfeld, Y., Sinico, R. A., Sousa, M.-J., Specks, U., Terrier, B., Tzioufas, A. G., Vermeire, S., Zhao, M.-H., & Bossuyt, X.
Venue
Autoimmunity Reviews
Publisher
Elsevier BV
Published
2020-09
Volume
19
Issue
9
Pages
102618
ISSN
1568-9972 (ISSN-L)
OpenAlex
W3041655488
Cited by
160
References
6
FWCI
10.47
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2020 international consensus on ANCA testing beyond systemic vasculitis. https://app.cochat.ai/papers/10.1016/j.autrev.2020.102618
The paper
Moiseev, S., Cohen Tervaert, J. W., Arimura, Y., Bogdanos, D. P., Csernok, E., Damoiseaux, J., Ferrante, M., Flores-Suárez, L. F., Fritzler, M. J., Invernizzi, P., Jayne, D., Jennette, J. C., Little, M. A., McAdoo, S. P., Novikov, P., Pusey, C. D., Radice, A., Salama, A. D., Savige, J. A., . . . Bossuyt, X. (2020). 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2020.102618

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.